Description
TIRZ: Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, designed to enhance glucose-dependent insulin secretion and decrease glucagon levels, effectively lowering blood sugar. It also improves insulin sensitivity and reduces body weight by slowing gastric emptying and curbing appetite. Studies show Tirzepatide’s potential benefits on heart health, liver function, and inflammatory markers, along with its ability to support weight management. As a GIP/GLP-1 analog, Tirzepatide offers a comprehensive approach to blood glucose regulation while promoting long-term metabolic health and overall well-being.
Warning: For Research Purposes Only. Injectables are delivered in a freeze-dried (powder) state, contained within a sterile vial. Use requires: Bacteriostatic Water for reconstitution.
Reviews
There are no reviews yet.